Pita JM,Figueiredo IF,Moura MM,et al.Cell cycle deregulation and TP53and RAS mutations are major events in poorly differentiated and undifferentiated thyroid carcinomas[J].J Clin Endocrinol Metab,2014,99(3):E497-E507.
[2]
Park JY,Kim WY,Hwang TS,et al.BRAF and RAS mutations in follicular variants of papillary thyroid carcinoma[J].Endocr Pathol,2013,24(2):69-76.
[3]
Cantwell ER,O’Leary JJ,Sheils OM,et al.BRAFV600E:implications for carcinogenesis and molecular therapy[J].Mol Cancer Ther,2011,10(3):385-394.
[4]
Marotta V,Guerra A,Sapio M,et al.RET/PTC rearrangement in benign and malignant thyroid diseases:a clinical standpoint[J].Eur J Endocrinol,2011,165:499-507.
[5]
Nikiforov YE.Molecular analysis of thyroid tumors[J].Mod Pathol,2011,24:S34-S43.
[6]
Elisei R,Viola D,Torregrossa L,et al.The BRAFV600E mutation is an independent,poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma:single-Institution results from a large cohort study[J].J Clin Endocrinol Metab,2012,97(12):4 390-4 398.
[7]
Hershman JM.Mutations of the RAS oncogene are found in follicular variant papillary thyroid carcinoma[J].Clin Thyroidol,2013,25:170-171.
[8]
Martina R,Mattia B,Federico T,et al.Relevance of BRAFV600Emutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer[J].Thyroid,2015,25(2):221-228.
[9]
Armstrong MJ,Yang H,Ohori NP,et al.PAX8/PPARγrearrangement in thyroid nodules predicts follicular-pattern carcinomas,in particular the encapsulated follicular variant of papillary carcinoma[J].Thyroid,2014,24(9):1 369-1 374.
[10]
Santoro M,Carlomagno F.Central Role of RET in Thyroid Cancer[J].Cold Spring Harb Perspect Biol,2013,5(12):a009233
[11]
Scollo C,Russo M,De Gregorio L,et al.A novel RET gene mutation in a patient with apparently sporadic pheochromocytoma[J].Endocr J,2015,[Epub ahead of print].
[12]
American Thyroid Association Guidelines Task Force,Kloos RT,Eng C,et al.Medullary thyroid cancer:management guidelines of the American Thyroid Association[J].Thyroid,2009,19:565-612.
[13]
Guerra A,Zeppa P,Bifulco M,et al.Concomitant BRAF V600E Mutation and RET/PTC Rearrangement Is a Frequent Occurrence in Papillary Thyroid Carcinoma[J].Thyroid.2014,24(2):254-259.
[14]
Sozopoulos E,Litsiou H,Voutsinas G,et al.Mutational and immunohistochemical study of the PI3K/Akt pathway in papillary thyroid carcinoma in Greece[J].Endocr Pathol,2010,21(2):90-100.
[15]
Chiosea S,Nikiforova M,Zuo H,et al.A novel complex BRAF mutation detected in a solid variant of papillary thyroid carcinoma[J].Endocr Pathol,2009,20:122-126.
[16]
Soares P1,Lima J,Preto A,et al.Genetic Alterations in Poorly Differentiated and Undifferentiated Thyroid Carcinomas[J].Curr Genomics,2011,12(8):609-617.
